News
ImmuCell Announces Financial Results for Second Quarter of 2018
PORTLAND, Maine, Aug. 13, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for Second Quarter of 2018
Conference Call Scheduled for Tuesday, August 14, 2018 at 9:00 AM ET PORTLAND, Maine, Aug. 07, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Hires Senior Director of Quality
PORTLAND, Maine, Aug. 07, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Sale of Certain Non-Core Assets
PORTLAND, Maine, July 25, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Preliminary Sales Results for Second Quarter of 2018
PORTLAND, Maine, July 10, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Join Russell Microcap Index
PORTLAND, Maine, June 25, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Financial Results for First Quarter of 2018
PORTLAND, Maine, May 14, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for First Quarter of 2018
Conference Call Scheduled for Monday, May 14, 2018 at 4:30 PM ET PORTLAND, Maine, May 07, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017
PORTLAND, Maine, Feb. 08, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2017
Conference Call Scheduled for Thursday, February 8, 2018 at 4:30 PM ET PORTLAND, Maine, Feb. 05, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...